The latest cohort analysis, this is the current week version, which just shows that week’s cohort. There is also a cumulative version, which shows the cumulative analysis for each week. As a reminder, the cohort analysis takes a week’s cases and goes forward during a defined lag period set by research from the CDC and others to identify likely hospitalizations and deaths among that set of cases. Gives you a sense of whether case rates are changing. Thanks again to DD. I am dubious about the rise in hospitalization rates. Likely reflects reduced testing among the young, reduced detection of infections among the vaccinated, and non CV-19 hospitalizations that are called CV-19 ones.
I thought you had stated that Ivermectin(sp) treatment was done in hospital, or at any rate considered a hospital treatment? Could this be part of the hospitalization statistics if more doctors are using it?
that is remdesivir, which for some bizarre reason the FDA has not approved as an outpatient infusion, so you have to be hospitalized to get it. I don’t think ivermectin requires hospitalization, but I am not 100% on that. Ivermectin is repurposed by physicians, it is not formally approved for use against CV-19 I believe.
Do some of the hospitalization stats reflect Ivermectin(sp) treatments? BTW if this comment looks redundant it’s because it’s the same person different email. Your blog doesn’t fancy yahoo so I am trying gmail but I’m not a robot I swear.